Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT
NCT00534989
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma, Non-Hodgkin
Hodgkin Disease
Interventions
PROCEDURE:
FDG PET
Sponsor
King Faisal Specialist Hospital & Research Center